Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Return on Capital Employed (2017 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Capital Employed for 4 consecutive years, with 0.21% as the latest value for Q3 2020.

  • On a quarterly basis, Return on Capital Employed rose 81.0% to 0.21% in Q3 2020 year-over-year; TTM through Sep 2020 was 0.21%, a 81.0% increase, with the full-year FY2019 number at 0.08%, up 49.0% from a year prior.
  • Return on Capital Employed was 0.21% for Q3 2020 at Forte Biosciences, down from 0.46% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 116.55% in Q1 2020 to a low of 0.7% in Q2 2018.
  • A 4-year average of 8.08% and a median of 0.49% in 2017 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -12bps in 2018, then surged 11715bps in 2020.
  • Forte Biosciences' Return on Capital Employed stood at 0.47% in 2017, then decreased by -21bps to 0.57% in 2018, then surged by 307bps to 1.19% in 2019, then tumbled by -82bps to 0.21% in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Return on Capital Employed are 0.21% (Q3 2020), 0.46% (Q2 2020), and 116.55% (Q1 2020).